Co-administration of proton pump inhibitors in patients prescribed long-term low-dose aspirin

Benefit, harm and cost-effectiveness

 

This project aims at answering the following question: 

Should patients prescribed long-term low-dose aspirin receive proton pump inhibitors? 

We have been trying to answer this question from both clinical and health economic points of view. Part of the answer has been published in the International Journal of Clinical Practice; access to this article is free for everyone because the article has been made as an Editors' Choice.